Evidence map›Paper›PMID 36132835›Full record

ArticleNanoscale advances2021

Tuneable manganese oxide nanoparticle based theranostic agents for potential diagnosis and drug delivery.

Kingsley Poon, Zufu Lu, Yves De Deene, Yogambha Ramaswamy, Hala Zreiqat, Gurvinder Singh

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanoscale advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Kingsley PoonARC Centre for Innovative BioEngineering, Tissue Engineering and Biomaterials Research Unit, Sydney Nano Institute, School of Biomedical Engineering, The University of Sydney NSW 2008 Australia hala.zreiqat@sydney.edu.au gurvinder.singh@sydney.edu.au.
Zufu LuARC Centre for Innovative BioEngineering, Tissue Engineering and Biomaterials Research Unit, Sydney Nano Institute, School of Biomedical Engineering, The University of Sydney NSW 2008 Australia hala.zreiqat@sydney.edu.au gurvinder.singh@sydney.edu.au.ORCID https://orcid.org/0000-0003-4843-4441
Yves De DeeneDepartment of Engineering, The Biomedical Engineering Laboratory, Macquarie University Sydney 2109 Australia.
Yogambha RamaswamyARC Centre for Innovative BioEngineering, Tissue Engineering and Biomaterials Research Unit, Sydney Nano Institute, School of Biomedical Engineering, The University of Sydney NSW 2008 Australia hala.zreiqat@sydney.edu.au gurvinder.singh@sydney.edu.au.
Hala ZreiqatARC Centre for Innovative BioEngineering, Tissue Engineering and Biomaterials Research Unit, Sydney Nano Institute, School of Biomedical Engineering, The University of Sydney NSW 2008 Australia hala.zreiqat@sydney.edu.au gurvinder.singh@sydney.edu.au.
Gurvinder SinghARC Centre for Innovative BioEngineering, Tissue Engineering and Biomaterials Research Unit, Sydney Nano Institute, School of Biomedical Engineering, The University of Sydney NSW 2008 Australia hala.zreiqat@sydney.edu.au gurvinder.singh@sydney.edu.au.ORCID https://orcid.org/0000-0001-9700-3344
The University of Sydney · AULaboratoire d’Imagerie Biomédicale · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among various magnetic nanoparticles, manganese oxide nanoparticles are considered as established

Identifiers

PMID36132835
PMCPMC9419237
OpenAlexW3171215490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.